Skip to content
Health Policy Watch
  • Home
  • About Us
  • Antimicrobial Resistance
  • Infectious Diseases
  • Pandemics & Emergencies
  • Non-Communicable Diseases
  • Health, Climate & SDGs
Single Dose Drug Effective For Recurrent Malaria, Trial Results Show
17/01/2019 Editorial team
A powerful new single-dose anti-malarial drug can significantly lower the risk of recurrent malaria from the Plasmodium vivax (P. vivax) species of the parasite, according to clinical trial results published today in the New England Journal of Medicine (NEJM). Continue reading ->
MMV: Zambia Pilot Project Reduces Malaria Mortality By 96 Percent
03/09/2018 David Branigan
A new pilot project conducted in a remote region of Zambia, MAMaZ Against Malaria, has demonstrated that with the right combination of access to medicines, trained community healthcare workers and rapid response rural transportation systems, malaria mortality in rural areas can be prevented, according to the project partnership. Continue reading ->

Posts navigation

Newer posts
This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Sign up for free news alerts
Signup Link
Contact Us
info@healthpolicy-watch.org
1-5 Route des Morillions CP 2100
Geneva 1211, Switzerland
+41 22 791 67 28
About
Privacy Policy
Archives
Staff Access
Log in
Entries RSS
Comments RSS
Wordpress.org
Supported by
Sponsors
Wellcome
CeHDI
Geneva
Loro
Copyright c 2020 Global Policy Reporting